News & Articles
Selected Filters:
More than 90% effective: Pfizer and BioNTech announce phase 3 COVID-19 vaccine results
Study enrolled 43,538 participants, with 42% having diverse backgrounds, and no serious safety concerns have been observed; Safety and additional efficacy data continue to be collected
Researchers to develop anti-COVID-19 coating for PPE
This project aims to produce an antiviral and antifouling coating which can be used on PPE to protect staff working in healthcare settings
Latest advances in protein biology
From ultrafiltration and extraction to glycosylation and imaging, discover the latest technologies, top tips, and best practices for protein biology research
PerkinElmer receives CE Mark for multi-analyte respiratory panel including COVID-19
Company’s latest test enables differential diagnosis between COVID-19, flu and RSV infection
EKF launches PrimeStore MTM pathogenic sample collection and transportation kit
New sample collection kit enables convenient and safe collection, transportation and handling of pathogenic samples including COVID-19 and influenza
Study shows high blood pressure and its drug treatment unlikely to increase entry of COVID-19 virus into cells
Study by University of Manchester reassures patients that it is safe to take blood pressure medication during the pandemic
Nominate your favorite new lab product for a Scientists’ Choice Award: Nominations open today
Which new products made the most difference to your lab work this year?
Combating cancer: The incubation technology accelerating CAR-T cell therapy development
Gene and cell therapy expert Dr. Gerhard Bauer explores the powerful therapies that use a patient's own immune cells to treat cancer
PerkinElmer introduces no-wash immunoassay to help drive neuroscience disease research forward
New kit aims to provide highly sensitive and efficient approach for studying mitophagy impairment in conditions such as Parkinson’s and Alzheimer’s
Study using Mission Bio’s Tapestri platform reveals clonal diversity underlying AML and therapy resistance
The study leverages the Tapestri Platform to illustrate the single-cell atlas of acute myeloid leukemia (AML) with multi-omics, describing the clonality underlying therapeutic resistance
Merck’s new VirusExpress platform speeds development of cell and gene therapies
Proven, scalable platform aims to increase dose yields and reduces process development time for cell and gene therapies
FDA approves Gilead's antiviral remdesivir drug for treatment of COVID-19
Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days
Roche announces collaboration with Atea Pharmaceuticals to develop a potential oral treatment for COVID-19 patients
Roche and Atea partner to jointly develop AT-527, an orally administered direct-acting antiviral (DAA) currently in Phase 2 clinical trials
Study shows novel mass screening method could slash COVID-19 testing costs
The hypercube algorithm aims to enable regular, cost-effective screening in multiple contexts
Limit of detection: The key to preventing false negative COVID-19 tests, regardless of patient viral load
Learn the importance of low LoD tests and discover the most sensitive kits available, as determined by the FDA’s SARS-CoV-2 Reference Panel
From sensitive detection to automated data management: Explore how Zymo Research is streamlining COVID-19 testing
Find out how Zymo Research’s state-of-the-art tools are helping laboratories and government agencies facilitate large-scale COVID-19 testing in the United States
COVID-19 breakthroughs: How pioneering scientists are advancing antibody therapies
Experts share novel techniques for accelerating monoclonal antibody discovery and development to bring hope to COVID-19 patients
The role of aberrant cytokine activity in the host immune response to COVID-19
Watch this webinar on demand to learn about the host immune response to COVID-19